Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma
Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma have?
Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma has 25 citations in the OpenAlex counts ScholarIQ stores.
When was Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma published?
Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma has 2022 year in the ScholarIQ index.
What is the open-access status of Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma?
Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma has gold oa status in the ScholarIQ index.
What is the DOI of Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma?
The DOI for Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma is on the source record.
What is the PMID of Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma?
The PMID for Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma is on the source record.
What is the OpenAlex record for Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma?
The OpenAlex for Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma is on the source record.